Short-Burst Interval Treadmill Training Cerebral Palsy
1 other identifier
interventional
60
1 country
2
Brief Summary
Ambulatory children with cerebral palsy (CP) walk predominately in low intensity stride rates with little variability, thus limiting their walking activity and ability to participate in daily life. In contrast, typically developing (TD) children engage in short bursts of intense walking activity interspersed with varying intervals of low intensity walking within daily life. In order to optimize motor learning, active participation, task-specific training and multiple repetitions or massed practice is required to learn new motor skills. Short bursts of vigorous intensity locomotor treadmill training (SBLTT) alternating with low/moderate intensity was specifically designed to mimic activity patterns of TD children in a massed practice format. Pilot data suggests that SBLTT is feasible and enhances walking capacity and performance in daily life for children with CP. This project will examine the effect of SBLTT versus an equivalent dosage of traditional locomotor treadmill training (TLTT) on the primary outcomes of walking capacity and performance in children with CP and whether the effects of SBLTT on walking capacity and performance are mediated by improvements in in muscle power generation. The scientific premise is that SBLTT, that approximates the walking intensity patterns of typically developing (TD) children through a home-based massed practice protocol, will be more effective than TLTT in improving walking capacity and performance. We hypothesize that SBLTT strategies for children with CP modeled on walking patterns of TD children, will be positively mediated by muscle power generation and subsequently improve walking capacity and community walking performance and mobility. Specific aims. Aim #1. Determine the immediate and retention effects of short-burst interval LTT (SBLTT) on walking capacity in ambulatory children with CP. Aim #2. Examine the effects of treatment on community-based walking activity performance and mobility. Aim #3. Explore whether the effects of SBLTT on walking capacity and performance are mediated by muscle power generation. The proposed research will be the first step in a continuum of research that is expected to direct locomotor training protocols and rehab strategies across pediatric disabilities and positively effecting the community walking performance and mobility for children with CP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2019
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 17, 2019
CompletedFirst Posted
Study publicly available on registry
July 19, 2019
CompletedStudy Start
First participant enrolled
November 27, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2025
CompletedJuly 30, 2025
July 1, 2025
5.5 years
July 17, 2019
July 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Walking Capacity-Self-selected walking speed
10 Meter Walk Test
Baseline to 8 weeks
Walking Capacity-Fast walking speed
10 Meter Walk Test- fast speed
Baseline to 8 weeks
Walking Capacity-Endurance
One Minute Walk Test
Baseline to 8 weeks
Walking Performance-level
StepWatch (SW) accelerometry - average total steps per day
Baseline to 8 weeks
Walking Performance-Intensity
StepWatch (SW) accelerometry - percent of strides/day in medium/high stride rates.
Baseline to 8 weeks
Knee extensor muscle power
Isokinetic Average Power for Knee extensors at 60deg/s as measured by Biodex.
Baseline to 8 weeks.
Secondary Outcomes (7)
Walking Mobility -level home
Baseline to 8 weeks
Walking Mobility-intensity home
Baseline to 8 weeks
Mobility-Patient Reported Outcome
Baseline to 8 weeks
Family Gait Priorities and Quality of gait
Baseline to 8 weeks
Knee extensor muscle torque
Baseline to 8 weeks.
- +2 more secondary outcomes
Study Arms (2)
Short burst Interval Treadmill Training (SBLTT)
EXPERIMENTALSBLTT will consist of short-bursts (30 seconds) of high speed walking alternating with 30 seconds of low/moderate speed walking. Participant will receive 40 home-based sessions (5x/week for 8 weeks) of SBLTT
Traditional Locomotor Treadmill Training (TLTT)
ACTIVE COMPARATORTLTT will consist of walking at steady-state speeds. Participant will receive 40 home-based sessions (5x/week for 8 weeks) of TLTT
Interventions
SBLTT will consist of short-bursts (30 seconds) of high speed walking alternating with 30 seconds of low/moderate speed walking. Total duration of walking per session will be up to 30 minutes of the 30 second alternating intervals (30sec high / 30sec low/moderate) with rests as needed. Both groups will receive 40 sessions delivered 5x/week for 8 weeks. Initial speeds for high speed walking will be 75-80% of each participant's over ground baseline fast walking speed, and low/moderate speed will be 75-80% of self-selected speed calculated from the 10-Meter Walk Test.
TLTT group will receive the same number of sessions (40) delivered 5x/week for 8 weeks with a total duration of walking per session up to 30 minutes with rests as needed. TLTT will consist of walking at steady-state speeds. Initial treadmill speed will be 75-80% of over ground self-selected walking speed. The overall goal will be to achieve 30 minutes of walking at a steady-state walking speed within each session. Speed will be increased on the next session by .1 to .4mph when the subject can walk for 30 minutes on the treadmill at the current speed with an OMNI score of \< 6/10.
Eligibility Criteria
You may qualify if:
- Bilateral and unilateral spastic cerebral palsy
- Gross Motor Function Classification Levels II \& III
- Ages 6 years to \< 11 years
You may not qualify if:
- Orthopedic or neurosurgery \< 9 months prior
- Injection therapy (Botulinum Toxin/Phenol) \< 3 months prior
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kristie Bjornsonlead
- University of Washingtoncollaborator
- Louisiana State University Health Sciences Center in New Orleanscollaborator
Study Sites (2)
Lousianna State University Health Sciences Center New Orleans
New Orleans, Louisiana, 70112, United States
Seattle Childrens Research Institute
Seattle, Washington, 98121, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kristie F Bjornson, PhD, PT
Seattle Children's Hospital
- PRINCIPAL INVESTIGATOR
Noelle Moreau, PhD, PT
Lousianna State University in New Orleans
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor, Pediatrics
Study Record Dates
First Submitted
July 17, 2019
First Posted
July 19, 2019
Study Start
November 27, 2019
Primary Completion
June 1, 2025
Study Completion
August 31, 2025
Last Updated
July 30, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share